Filter news by category :
01 Mar 2023 | Corporate
Dr Christophe Portal has been appointed as Chief Scientific Officer. Christophe has 15 years of industrial experience in the research and development of peptide and peptide like molecules for imaging and therapy. He started his career working for a biotechnology company developing optical imaging...
01 Mar 2023 | Corporate
Dr Alex Gibson has been appointed as Chief Executive Officer. Alex has over 25 years of experience in the radiopharmaceutical industry starting as a radiochemist with Amersham (now part of GE Healthcare). Following several roles within imaging pharmaceutical R&D, Alex spent the lat 5 years of...
01 Mar 2023 | Corporate, Events
Edinburgh Molecular Imaging appoints Dr Rob James as Non-Executive Chairman Rob is currently the Managing Partner of Sixth Element Capital and has over 20 years of experience of working in early-stage companies developing oncology drugs. He first worked at Cancer Research Campaign Technology (now...
08 Nov 2018 | Corporate, Press Releases
Seasoned CEO with 30 years’ experience in the healthcare industry Edinburgh, United Kingdom - 8 November 2018 – Edinburgh Molecular Imaging (EM Imaging), the optical molecular imaging company, today announces the appointment of Dr Bernhard Sixt as Chief Executive Officer, effective immediately....
29 Oct 2018 | Corporate, Press Releases
EDINBURGH, Scotland, October 29, 2018 - Roy Davis appointed as Non-Executive Chairman - Current Chair John Jeans to continue as Non-Executive Director Edinburgh Molecular Imaging Ltd (EM Imaging), the clinical phase biotechnology company focused on enabling image-guided therapy, announces the...